The gut-brain axis in Parkinson's disease

Area of Science:

• Neuroscience
• Gastroenterology
• Microbiology

Background:

• The gut-brain axis describes bidirectional communication between the gastrointestinal tract and the brain via the autonomic nervous system.
• Growing evidence links gastrointestinal inflammation and neurodegeneration, supporting the gut-brain axis concept.
• Aberrant microbiota-gut-brain interactions are implicated in Parkinson's disease (PD) pathogenesis.

Purpose of the Study:

• To explore the role of the microbiota-gut-brain axis in Parkinson's disease.
• To investigate the hypothesis that PD originates in the gut and spreads to the central nervous system.
• To identify potential therapeutic targets within the gut-brain axis for PD management.

Main Methods:

• Review of existing literature on the gut-brain axis, gastrointestinal inflammation, neurodegeneration, and Parkinson's disease.
• Analysis of evidence supporting the gut-to-brain transmission hypothesis in PD.
• Identification of therapeutic strategies targeting the gut-brain axis.

Main Results:

• An abnormal microbiota-gut-brain interaction is a contributing factor to Parkinson's disease.
• Evidence suggests PD may originate in the gut and propagate to the central nervous system, potentially via the vagus nerve.
• The gut-to-brain axis presents potential therapeutic avenues for PD.

Conclusions:

• The gut-brain axis is a critical factor in Parkinson's disease.
• Targeting the gut-to-brain axis, including vagus nerve stimulation, fecal microbiota transplantation, and gut-protective agents, may be beneficial for PD management.